Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Sigan Industries Group Inc.
Chemical Contamination: Presence of benzene
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
Glenmark Pharmaceuticals Inc., USA
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
Amgen, Inc.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Amgen, Inc.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Sensipar (30mg, 60mg, 90mg)
Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…
MYLAN PHARMACEUTICALS INC
Failed Dissolution Specifications - low dissolution results
A-S Medication Solutions LLC
Presence of Foreign Tablets/Capsules.
Kowa Pharmaceuticals America
Presence of foreign tablets/capsules
Denison Pharmaceuticals, LLC
Chemical Contamination: Presence of benzene.
Imprimis NJOF, LLC
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
Central Admixture Pharmacy Services, Inc.
Presence of Particulate Matter
One Source Nutrition, Inc,
Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.
Turbare Manufacturing
Lack of Assurance of Sterility: due to a quality control process deviation
BD ChloraPrep™ Clear - 1mL Applicator
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Safecor Health, LLC
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Safecor Health, LLC
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Safecor Health, LLC
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Safecor Health, LLC
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Safecor Health, LLC
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.